Brent Ahrens
General Partner / West Coast·Canaan Partners
Brent Ahrens is a General Partner and West Coast healthcare investor at Canaan, where he has worked since 1999. He leads investments across healthcare with a focus on biopharma and medtech; prior to Canaan he worked in commercial and technical roles at General Surgical Innovations, Ethicon Endo-Surgery, and IAP Research. His firm bio lists current and prior investments including Abyrx, EndoGastric Solutions, Grey Wolf Therapeutics, Iterum Therapeutics, Pathios, Relievant Medsystems, Transposon Therapeutics, DexCom, Durata Therapeutics, and Peninsula Pharmaceuticals.
See the rest of Brent Ahrens's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.